SwatiGoelMD

Myeloproliferative Disorder Hematology-Oncology

Associate Professor, Medicine, A Einstein Coll of Med of Yeshiva Univ

Dr. Goel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3411 Wayne Ave
Bronx, NY 10467
Phone+1 718-920-4137

Fax+1 718-882-8698

Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 2007 - 2010
All India Institute of Medical SciencesClass of 2005

PubMed

35 citations
On-admission anemia predicts mortality in COVID-19 patients: A single center, retrospective cohort study.
Seung Mi Oh, John P. Skendelas, Eric MacDonald, Michael Bergamini, Michael Bergamini
The American Journal of Emergency Medicine. 2021-03-29
31 citations
High prevalence and allele burden-independent prognostic importance of p53 mutations in an inner-city MDS/AML cohort.
Swati Goel, Jeff Hall, Kith Pradhan, Cassandra M. Hirsch, Bartlomiej P Przychodzen
Leukemia. 2016-08-01
85 citations
ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial.
Stephen T. Oh, Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srdan Verstovsek
Blood Advances. 2020-09-22

Abstracts/Posters

Direct Oral Anticoagulants for Prevention of Recurrent Thrombosis in Myeloproliferative Neoplasms
Swati Goel, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Using Sociodemographic Data to Predict Survival in MyelofibrosisOctober 1st, 2024